Event Preview | The Pujiang Innovation Forum · The 2026 Brain-Computer Interface Conference Investment and Financing Sub-forum will be held in Shanghai on November 27
Event Preview | The Pujiang Innovation Forum · The 2026 Brain-Computer Interface Conference Investment and Financing Sub-forum will be held in Shanghai on November 27
2026 Brain-Computer Interface Conference Investment and Financing Sub-forum
On the afternoon of November 27, 2026,Pujiang Innovation Forum · 2026 Brain-Computer Interface Conference Investment and Financing Sub-forumwill be held at Shanghai Brain Intelligence World. Frost & Sullivan (hereinafter referred to as "Frost & Sullivan") will join Brain-Computer New Voice to gather investment institutions, industry funds, brain-computer interface innovation companies, and industry experts from home and abroad. The forum will discuss key topics such as the global development trends of the brain-computer interface industry, investment value assessment, corporate financing, and capitalization paths, and explore cooperation opportunities between cutting-edge technological innovation and the capital market.
This sub-forum will rely on Frost & Sullivan's professional expertise in global industry research, enterprise valuation, commercial due diligence, and capital market services. It will focus on key investment issues in the brain-computer interface industry, providing a professional exchange platform for investment institutions to gain deeper insights into the industry's forefront and for innovative companies to connect with capital resources.
Based in Shanghai, facing the world, discussing the future of the brain-computer interface industry
As a cutting-edge field deeply integrated with neuroscience, artificial intelligence, information technology, and life sciences, the brain-computer interface is becoming an important direction for global technological innovation and future industry development.
In recent years, with continuous progress in neural signal acquisition, intelligent decoding, neural regulation, and clinical applications, the application potential of brain-computer interfaces has expanded, and global research institutions, technology companies, and investment institutions have increasing attention to this field.
Currently, the global brain-computer interface industry is in an important stage of accelerated technological innovation, deepening clinical applications, and exploring industrialization. The global industry is actively exploring the long-term development path of brain-computer interfaces around key issues such as core technology breakthroughs, industrial chain construction, clinical transformation of results, business model innovation, and capital allocation.
Under this background,The Pujiang Innovation Forum · 2026 Brain-Computer Interface Conference, with the theme "Connecting the World through the Brain · Gathering Wisdom in Shanghai," will be held in Shanghai from November 27 to 29, 2026.
The conference is based on the construction of Shanghai as an international technology innovation center, targeting the global brain-computer interface industry. It aims to establish a high-level, international platform for technology innovation and industrial cooperation, promoting exchanges and cooperation among global cutting-edge technologies, innovative results, industrial resources, and capital elements.
This conference will invite representative research institutions, clinical experts, technology companies, investment institutions, and industry professionals from home and abroad to discuss global development trends, industrial innovation ecosystems, clinical application prospects, and commercialization paths of brain-computer interfaces, and jointly explore opportunities and challenges in the development of the brain-computer interface industry.
Thanks to Shanghai's comprehensive advantages in technology innovation, life and health, advanced manufacturing, and international finance, the conference will further strengthen the connection between global brain-computer interface innovation resources and industrial resources, promoting international technology cooperation, innovation result transformation, and coordinated industrial chain development.
Focusing on industrial investment opportunities, discussing the long-term capital value of brain-computer interfaces
As brain-computer interface technologies gradually move from laboratory research to clinical validation and industrialization exploration, the global capital market's attention to this field is deepening, and the industrial investment logic is continuously evolving.
From invasive, semi-invasive to non-invasive brain-computer interfaces, from core components such as chips, electrodes, and sensors to system integration, clinical applications, and commercial services, the brain-computer interface industry is forming a more diverse technical system and industrial ecosystem. Different technical routes have significant differences in research cycles, technical maturity, clinical applications, product registration, and commercialization paths, which also require higher professional research capabilities and long-term investment value assessments from investment institutions.
Which technical routes have long-term competitiveness? How to evaluate the technical barriers and clinical application value of innovative projects? Which industrial chain segments offer ongoing investment opportunities? How to assess the commercialization potential, valuation level, and capitalization timing of brain-computer interface companies?
These questions are gradually becoming important focuses for investment institutions to study the brain-computer interface industry.
As an important special activity focusing on the capital market this year, the Frost & Sullivan Pujiang Innovation Forum · 2026 Brain-Computer Interface Conference Investment and Financing Sub-forum will conduct professional discussions on investment logic, technical value assessment, clinical transformation, corporate financing, and capitalization paths of brain-computer interfaces.
According to the preliminary agenda, the forum will include a keynote speech on industrial investment and financing trends, a special sharing on medical device registration and capitalization paths, and roundtable discussions on technical barriers and clinical value assessment, corporate financing and merger and acquisition paths.
The forum will invite government-guided funds, industry investment funds, VC/PE institutions, investment departments of listed companies, brain-computer interface innovation companies, and related professional service institutions to participate. Combining global industry development trends and actual investment cases, it will discuss investment opportunities in the brain-computer interface field and the long-term growth value of enterprises.
Leveraging the global capital market's professional advantages, deepening the study of industrial investment value
As a globally renowned professional consulting service provider for investment and business growth, since its establishment 65 years ago, Frost & Sullivan has used nearly 50 offices worldwide, leveraging a powerful database and expert pool, and employing rich professional knowledge and consulting tools to help over 10,000 clients accelerate their growth, helping clients achieve growth, innovation, and leading positions in the industry, and realize capital operation goals such as financing and listing.It has extensive professional experience in enterprise valuation, commercial due diligence, listing industry consulting, investment and financing consulting, and merger and acquisition transactions.
In the capital market field, Frost & Sullivan has long maintained cooperation with globally renowned investment banks, accounting firms, law firms, and professional investment institutions. Frost & Sullivan has already helped nearly three thousand companies successfully list in Hong Kong and overseas. In the past 10 years, Frost & Sullivan has consistently held the leading position in the market share of industry research consultants for Chinese companies listing in Hong Kong and overseas.According to LiveReport's big data statistics, industry consultants are essential intermediary institutions before new shares are listed in Hong Kong. Among the 527 companies that submitted applications in the first eight months of 2026, Frost & Sullivan participated in 368 companies, accounting for 69.83%. The remaining 12 industry consultants collectively participated in 159 companies, accounting for 30.17%. In recent years, Frost & Sullivan's reports have also been widely used in the prospectus documents of leading A-share and Sci-Tech Innovation Board listed companies, as well as research reports for the primary and secondary markets and other capital market public documents.
During the process of enterprise investment and financing and capitalization, Frost & Sullivan can conduct research on dimensions such as industry market size, competitive landscape, technical advancement, business model, and future growth potential, providing professional support for enterprise strategic planning, commercial due diligence, valuation analysis, and capital market communication. Its financial consulting services also cover pre-listing financing, investment target screening, investor connection, due diligence, transaction valuation, and merger and acquisition consulting.
Therefore, for the cutting-edge technology field of brain-computer interfaces, industrial investment needs to comprehensively consider technical maturity, clinical application value, regulatory paths, target market size, and enterprise commercialization capabilities. Frost & Sullivan will rely on its experience in global industry research and capital market services to further study the commercial value of brain-computer interface technology, industrial chain investment opportunities, and capitalization paths of innovative companies, providing a more systematic analytical perspective for industrial investment institutions and promoting effective connection between industrial innovation and the capital market.
Gathering high-quality innovative projects, promoting precise connection between industry and capital
Regarding the financing needs of brain-computer interface innovation companies, this investment and financing sub-forum will also includeInnovation project roadshow and targeted investor connection session, promoting exchanges between innovative companies with technical innovation capabilities and industrial potential and professional investment institutions.
According to the preliminary plan, the forum will invite 6 to 8 representative brain-computer interface innovation projects to conduct on-site roadshows, focusing on displaying the company's core technologies, research and development progress, clinical applications, business model, and future development plans.
The project roadshow will focus on innovative and growth-potential technologies and enterprises in the brain-computer interface field, providing investment institutions with an opportunity to understand industry frontline projects, and establishing a professional communication channel between innovative enterprises and the capital market.
The forum also plans to invite government-guided funds, industry investment funds, VC/PE institutions, investment departments of listed companies, and other professional investment institutions to participate in targeted exchanges, conducting in-depth discussions on enterprise financing needs, technical commercial value, industrial cooperation, and future development plans.
Through activities such as industry trend discussions, roundtable discussions, innovation project displays, and investor connections, this forum will further promote exchanges and cooperation between industrial research results, innovative technologies, and capital resources, creating more opportunities for the financing development and technology transformation of brain-computer interface innovation enterprises.
Deepening industrial research cooperation, continuously monitoring the global brain-computer interface development
On August 5, 2026, during the 20th Frost & Sullivan Global Growth, Innovation and Leadership Summit and the 5th New Investment Conference, Frost & Sullivan and Brain-Computer New Voice officially signed a strategic cooperation agreement and announced the joint establishment of theGlobal Brain-Computer Interface Industry Research Center, and subsequently released the "Global Brain-Computer Interface Industry Development White Paper (2026)."
The Global Brain-Computer Interface Industry Research Center is based in China but targets the global market, focusing on the evolution of brain-computer interface technology, clinical applications, regulatory policies, industrial chain construction, capital trends, and global competition landscape. It aims to establish an industry research and resource collaboration platform with international vision and professional depth.
From left to right: Mr. Xie Baozeng, CEO of Brain-Computer New Voice; Mr. Yang Xiaocheng, Senior Partner and Managing Director of Frost & Sullivan China
Previously released"Global Brain-Computer Interface Industry Development White Paper (2026)"provided a systematic study of the brain-computer interface industry from dimensions such as core technical system, medical applications, life and industrial applications, global regulatory paths, industry development environment, and representative enterprises, providing professional references for government agencies, industrial enterprises, and investment institutions to understand the global brain-computer interface industry.
This investment and financing sub-forum is an important practice of Frost & Sullivan to continue deepening industrial research on brain-computer interfaces and promote industrial-capital exchange.
Based on the existing global brain-computer interface industry research results, Frost & Sullivan will further focus on the technical commercialization process of brain-computer interface enterprises, industrial investment value, and capital market development paths, promoting effective connection between global industrial research resources and innovative enterprises and professional investment institutions.
Additionally, both parties plan to release the "Global Brain-Computer Interface Supply Chain White Paper (2027)" during this conference, further conducting systematic research on core devices, key materials, chips, electrodes, algorithms, precision manufacturing, and related industrial services, providing references for investment institutions to identify industrial chain development opportunities, enterprises to formulate development strategies, and all parties to engage in supply chain cooperation.
Participate in the cooperation
Please contact us
Frost & Sullivan China
Senior Partner and Managing Director Yang Xiaocheng
Email: jacky.yang@frostchina.com
Frost & Sullivan China
Consulting Director Sun Rong
Email: skyler.sun@frostchina.com
Long press to scan the QR code below, and we will contact you
On November 27, meet in Shanghai to explore investment opportunities in the brain-computer interface industry
The development of the brain-computer interface industry requires continuous technological innovation, clinical verification, industrial collaboration, and long-term capital support. As global brain-computer interface technology continues to make progress, in-depth exchanges between industry and capital will create more cooperation opportunities for the transformation of innovative results and enterprise growth.
On the afternoon of November 27, 2026, the Frost & Sullivan Pujiang Innovation Forum · 2026 Brain-Computer Interface Conference Investment and Financing Sub-forum will be held at Shanghai Brain Intelligence World.
Frost & Sullivan sincerely invites VCs, PE, government-guided funds, industry investment funds, investment departments of listed companies, family offices, brain-computer interface innovation companies, and related professional institutions worldwide to participate in this forum, to engage in in-depth exchanges with innovative enterprises, research and development experts, and clinical experts on the front line, and to jointly discuss the global development trends, investment logic, and capital cooperation opportunities of the brain-computer interface industry.
We look forward to meeting with colleagues from the global industry and investment community in Shanghai to jointly explore the long-term development value of the brain-computer interface industry.
Forum Information
Event Name:Frost & Sullivan Pujiang Innovation Forum · 2026 Brain-Computer Interface Conference Investment and Financing Sub-forum
Event Time:November 27, 2026 (for details, please refer to the specific agenda)
Event Location:Shanghai Brain Intelligence World
Forum Topics:Global brain-computer interface industry investment and financing trends, technical value assessment, medical device registration and capitalization paths, innovation project roadshow and investment institution connections
Participants:VC/PE institutions, government-guided funds, industry funds, investment departments of listed companies, family offices, brain-computer interface innovation companies, and professional service institutions
Long press to scan the QR code below, and we will contact you
For the specific agenda, participating guests, and project roadshow arrangements, please refer to the final announced information.
Scan the QR code to communicate in advance
The chain of brain-computer interfaces is long—electrodes, chips, sensors and materials, algorithm decoding and system integration, clinical verification and rehabilitation devices, all the way to consumer products; there are many participants, including research teams, clinical doctors, device manufacturers, complete machine enterprises, investment institutions, parks, and industry funds. No matter which part you are in, you can find us through the entrance below.
Attendance and Exhibition: Industrial enterprises can apply for booths to display core devices, complete machine products, or clinical solutions; universities, medical institutions, industrial parks, and industry organizations can group up to attend exhibitions.
Enterprise Roadshow Applications: Brain-computer interface enterprises in the stage of clinical verification or industrialization can apply for a spot in the investment and financing sub-forum roadshow, presenting their core technologies, research and development progress, and commercialization plans to investment institutions.
Investor Participation: VC/PE, government-guided funds, industry funds, investment departments of listed companies, and family offices can register to participate and schedule targeted connections with roadshow projects.
Add the following WeChat, note "Name + Unit + Attendance/Exhibition/Roadshow/Investment"
Business Consultation Hotline
(021) 54075836
Scan to add official WeCom customer service for online support.
Scan to follow our official WeChat
